Carthera Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 13

Carthera General Information

Description

Operator of a clinical-stage medtech company intended to develop ultrasound-based medical devices to treat brain disorders. The company's devices are intracranial ultrasound implants in combination with intravenous injection of a microbubble agent that temporarily opens the blood-brain barrier and makes way for an increased concentration of therapeutic molecules to reach the brain, enabling doctors with potential cures for debilitating neurological conditions.

Contact Information

Website
www.carthera.eu
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1 Place Vaclav Havel
  • Immeuble Weitz
  • 69007 Lyon
  • France
+33 04
Primary Industry
Therapeutic Devices
Corporate Office
  • 1 Place Vaclav Havel
  • Immeuble Weitz
  • 69007 Lyon
  • France
+33 04

Carthera Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Carthera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Secondary Transaction - Private Completed Clinical Trials - Phase 3
13. Later Stage VC (Series B) 27-Jun-2023 Completed Clinical Trials - Phase 3
12. Later Stage VC (Series B) 21-Nov-2022 Completed Clinical Trials - Phase 3
11. Later Stage VC 14-Sep-2020 Completed Clinical Trials - Phase 3
10. Grant 18-Mar-2020 Completed Clinical Trials - Phase 3
9. Later Stage VC 20-Dec-2019 Completed Clinical Trials - Phase 3
8. Later Stage VC (Series B) 12-Dec-2018 Completed Clinical Trials - Phase 3
7. Later Stage VC 08-Nov-2016 Completed Clinical Trials - Phase 3
6. Grant 13-Oct-2016 $6.38M $3.32M Completed Clinical Trials - Phase 3
5. Accelerator/Incubator $3.32M Completed Clinical Trials - Phase 3
To view Carthera’s complete valuation and funding history, request access »

Carthera Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
ADPB
ABSA 2
ADP A
Ordinary
Preference 72,700 $0.100691 $32.22 $32.22 1x $32.22 8.81%
Preference 27,400 $0.100691 $20.14 $20.14 1x $20.14 3.32%
To view Carthera’s complete cap table history, request access »

Carthera Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a clinical-stage medtech company intended to develop ultrasound-based medical devices to treat brain disorde
Therapeutic Devices
Lyon, France
20 As of 2023

Artarmon, Australia
 

Aliso Viejo, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Carthera Competitors (22)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Saluda Medical Venture Capital-Backed Artarmon, Australia
Neuros (Healthcare Technology Systems) Venture Capital-Backed Aliso Viejo, CA
Fisher Wallace Labs Venture Capital-Backed New York, NY
Mainstay Medical Venture Capital-Backed San Diego, CA
Cala Health Venture Capital-Backed San Mateo, CA
You’re viewing 5 of 22 competitors. Get the full list »

Carthera Patents

  • 71

    Total Documents Applications and Grants

  • Total Patents Families

  • 57

    Granted

  • 11

    Pending

  • Expiring in next 12 mo

Carthera Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3131218-A1 Method and system for detecting a connection terminal Active 28-Dec-2021
FR-3131218-B1 Method and system for detecting a connection terminal Active 28-Dec-2021
JP-2023516040-A Method and system for detecting poor acoustic coupling between an ultrasound device and tissue to be treated Pending 02-Mar-2020
FR-3107651-B1 Method and system for detecting an acoustic coupling defect between an ultrasound device and a tissue to be treated Active 02-Mar-2020
FR-3107651-A1 Method and system for detection of an acoustic coupling fault between an ultrasound device and a fabric to be treated Active 02-Mar-2020 A61N7/00
To view Carthera’s complete patent history, request access »

Carthera Executive Team (7)

Name Title Board Seat
Frédéric Sottilini Chief Executive Officer & Directeur Général
Matthieu Cholvy Chief Technical Officer
Michael Canney Chief Scientific Officer
Carole Desseaux Chief Clinical Officer & Head of Clinical Affairs
Alexandre Carpentier Co-Founder & Board Member
You’re viewing 5 of 7 executive team members. Get the full list »

Carthera Board Members (8)

Name Representing Role Since
Alexandre Carpentier Carthera Co-Founder & Board Member
Alexis Longevialle Self Board Member
Bervin Bouani Turenne Groupe Board Member
Celia Hart Ph.D Supernova Invest Board Member
Diana Saraceni Panakes Partners Board Member
You’re viewing 5 of 8 board members. Get the full list »

Carthera Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Carthera Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Relyens Impact Investing Minority
Unorthodox Ventures Venture Capital Minority
BOUSCAS Venture Capital Minority
Saint-Genys Venture Capital Minority
European Innovation Council Fund Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

Carthera FAQs

  • When was Carthera founded?

    Carthera was founded in 2009.

  • Who is the founder of Carthera?

    Alexandre Carpentier, Murielle Lemoine, and Delphine Ferriere are the founders of Carthera.

  • Who is the CEO of Carthera?

    Frédéric Sottilini is the CEO of Carthera.

  • Where is Carthera headquartered?

    Carthera is headquartered in Lyon, France.

  • What is the size of Carthera?

    Carthera has 20 total employees.

  • What industry is Carthera in?

    Carthera’s primary industry is Therapeutic Devices.

  • Is Carthera a private or public company?

    Carthera is a Private company.

  • What is Carthera’s current revenue?

    The current revenue for Carthera is .

  • How much funding has Carthera raised over time?

    Carthera has raised $89.9M.

  • Who are Carthera’s investors?

    Relyens, Unorthodox Ventures, BOUSCAS, Saint-Genys, and European Innovation Council Fund are 5 of 13 investors who have invested in Carthera.

  • Who are Carthera’s competitors?

    Saluda Medical, Neuros (Healthcare Technology Systems), Fisher Wallace Labs, Mainstay Medical, and Cala Health are some of the 22 competitors of Carthera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »